Total Cost Base
₹332 Cr
People ₹202 Cr + Capex ₹130 Cr
People Cost
₹202 Cr
60.8% of total · 2,589 FTEs
Capex Budget
₹130 Cr
39.2% · 420 line items
FY27E Revenue
₹550 Cr
People/Rev = 36.7%
New Hires FY27
244
41 Docs + 203 Staff · ₹18.3 Cr
Outsourced
416
19% of workforce · ₹12.9 Cr
🔍 Strategic Cost Architecture — FY27 Budget
Total FY27 cost base: ₹332 Cr — 61% people cost (₹202 Cr across staff salary, doctor fees, outsource) and 39% capex (₹130 Cr). Doctor cost totals ₹99 Cr (49% of people cost, including prof fees, incentives, visiting share). 76% of capex (₹99 Cr) targets clinical capabilities — spine robotics, biplane cathlab, tomotherapy — aligning cost deployment with the cancer & complex care transformation thesis. Staff-to-bed ratio at 3.8x signals productivity optimization potential.
Cost Bridge — FY27 Budget Decomposition (₹ Crore)
People cost blocks (left) · Capex blocks (right)
Cost Split
People ₹202 Cr · Capex ₹130 Cr
People Cost Composition — ₹189 Cr
Salary, professional fees, outsource, benefits & overhead
Capex Strategic Allocation — ₹130 Cr
Growth vs maintenance vs infrastructure spend
On-Roll Staff
2,173
1,842 staff + 258 docs + 73 trainees
Outsourced
416
HK, Security, Ward Boys, Nursing Asst
Total Workforce
2,589
Across 3 units
Staff : Bed
3.8x
2,173 / ~570 beds
Avg Cost/FTE
₹61K
Blended monthly
Increment Budget
₹10.0 Cr
Staff 8% + Doctor 10%
💡 Manpower Insight
Nursing is the largest cost center at ₹34.6 Cr (20.9%) with 827 FTEs. However, Consultants, though only 7.3% of headcount (159 people), consume 41.3% of on-roll cost (₹68.4 Cr in on-roll budget) — making doctor economics the single most important cost lever. The headcount-to-cost inversion between nursing and consultants is the defining structural feature of the cost base.
Headcount by Staff Category
On-roll 2,173 employees · Largest: Nursing 687, Paramedical 607
Cost by Staff Category (₹ Lakhs)
Consultants dominate despite low headcount · ₹16,563L total on-roll
Top 20 Departments by People Cost
Click column headers to sort · On-roll staff only · Amounts in ₹ Lakhs
| # | Department | Headcount | Cost ₹L | % of Total |
Avg Cost/Person ₹L | Category Mix | Tier |
Headcount vs Cost — The Inversion Effect
Category Share: Headcount vs Cost
Consultants = 7.3% of people but 41.3% of cost · Nursing = 31.6% of people but 17.3% of cost
Total Doctor Cost
₹99 Cr
Prof Fee + Incentive + DNB + Salaried
Fixed Prof. Fee
₹61 Cr
159 consultants · Avg ₹3.2L/mo
Revenue Incentive
₹13.2 Cr
2.68% of revenue
Visiting Share
₹8.3 Cr
1.6% Kochi + 10% Calicut
New Doc Hires
41
₹11.3 Cr annual budget
Doctor/Revenue
18.0%
₹99 Cr / ₹550 Cr target
🚨 Critical: Doctor Fee Structure — Fixed vs Variable Mix
61% of doctor cost (₹61 Cr) is fixed professional fee — independent of revenue generation. Only ₹21.5 Cr (21.7%) is truly variable (revenue-linked incentive + visiting consultant share). This creates downside rigidity: in a revenue shortfall scenario, doctor costs don't flex. New hires should be structured with higher variable / lower fixed to improve margin flexibility. Average consultant cost: ₹43L/year (₹3.2L/month fixed fee) — competitive for Kerala but premium vs national benchmarks.
Doctor Cost Structure Breakdown
Fixed fee dominates · Limited variable linkage
New Doctor Hires — FY27 Plan (41 positions)
Strategic speciality additions · ₹11.3 Cr annual
New Doctor Hires — Speciality Detail
Aligned with cancer & complex care transformation — Oncology, Transplant, Critical Care hiring
| Speciality | Designation | Count | Monthly ₹L | Annual ₹L | Strategic Fit |
|---|
| Medical Oncology | Consultant | 2 | 4.0L each | 96.0 | Core Onco |
| Head & Neck Oncology | Assoc. Consultant + Consultant | 4 | 2.0–3.0L | 120.0 | Core Onco |
| Liver Transplant | Consultant + SR | 3 | 1.0–4.0L | 108.0 | Transplant |
| Critical Care | Consultant + SR + JR | 10 | 0.5–3.5L | 144.0 | Complex |
| Haematology | Haematologist | 1 | 5.0L | 60.0 | Core Onco |
| Cardiology | Consultant + EP | 2 | 4.0–5.0L | 108.0 | Growth |
| PICU | Intensivist | 1 | 7.0L | 84.0 | Complex |
| Infectious Diseases | Consultant | 1 | 5.0L | 60.0 | Growth |
| Nephrology | Assoc. Consultant + SR | 2 | 1.5–2.5L | 48.0 | Growth |
| Other 15 Specialities | Various | 15 | 0.5–3.5L | 306.0 | Support |
| Total | | 41 | | 1,134 | |
Outsourced Staff
416
19.1% of total workforce
Annual Cost
₹12.9 Cr
inc GST 18%
Avg Cost/Head
₹25.8K
Per month blended
HK Staff
194
47% of outsource · ₹6.6 Cr
Cost Spread
₹11K
Between cheapest & costliest vendor
⚠️ Vendor Fragmentation — Consolidation Opportunity
3 separate vendors for housekeeping with a ₹11K/month spread in per-head costs (₹17K Abad vs ₹28K Professional Hospitality). Consolidating to 1-2 vendors and negotiating volume rates could save ₹1-2 Cr annually. Security & ward boys (175 staff) are single-vendor (Utiz) — creates vendor lock-in risk.
Outsource Cost by Function
Housekeeping = 51% of outsource spend
Cost per Head by Vendor (₹/month)
Wide spread = consolidation opportunity
Outsource Vendor Detail
Full breakdown by function, vendor, unit · Annual costs include GST
| Function | Vendor | Unit | Heads | Cost/Head/Mo | Annual ₹L | % Share |
|---|
| Housekeeping | Naipunnya Welfare | Kochi | 124 | ₹22,400 | 438 | 34.0% |
| Housekeeping | Prof. Hospitality | Kochi | 32 | ₹28,700 | 132 | 10.2% |
| Housekeeping | Abad Property | FNB | 34 | ₹17,100 | 84 | 6.5% |
| Housekeeping | Utiz Resource | Calicut | 4 | ₹15,900 | 9 | 0.7% |
| HK Subtotal | | | 194 | ₹22,500 avg | 663 | 51.4% |
| Security & Fire | Utiz Resource | Kochi + Cal | 99 | ₹22,200 | 307 | 23.8% |
| Ward Boys | Utiz Resource | Kochi | 76 | ₹18,100 | 195 | 15.1% |
| Nursing Assistants | Team 4 Facility | Kochi | 44 | ₹18,100 | 112 | 8.7% |
| MRD Assistants | Team 4 Facility | Kochi | 3 | ₹17,400 | 7 | 0.6% |
| Grand Total | | | 416 | ₹25,800 avg | 1,290 | 100% |
Clinical Growth
₹76 Cr
58% · Robotics, CathLab, Onco
Equipment Upgrade
₹23 Cr
17% · Ventilators, Imaging, Labs
Infrastructure
₹20 Cr
15% · Casualty, ICU, Parking
IT & Digital
₹5 Cr
3.8% · Network, Oracle prep
Safety & Compliance
₹3.4 Cr
3% · Fire curtains, alarm
Capex / Bed
₹22.8L
₹130 Cr / 570 beds
✅ Capex Aligned to Transformation Thesis
76% of capex (₹99 Cr) targets clinical capabilities — split between transformative growth (₹76 Cr: spine robotics ₹12 Cr, biplane cathlab ₹11 Cr, tomotherapy ₹2.3 Cr) and equipment refresh (₹23 Cr). Top 3 items alone = ₹27.4 Cr (21% of capex), creating two new quaternary verticals. Biomedical department = 73% of total capex.
Capex by Strategic Category
Growth vs Maintenance vs Infrastructure
Capex by Department (₹ Crore)
Biomedical dominates at 73% of total
Top 20 Capex Items — Strategic Assessment
Ranked by total budgeted cost · Strategic lens: Growth / Upgrade / Infrastructure / Compliance
| # | Item | Department | Cost ₹ Cr | Category | Strategic Rationale |
|---|
| 1 | Spine Robotic System | Biomedical | 12.00 | Growth | Quaternary care differentiator — Kerala's first |
| 2 | Biplane Cathlab | Biomedical | 11.00 | Growth | Interventional cardio anchor investment |
| 3 | Multi Level Parking | Engineering | 4.41 | Infra | Patient experience & capacity unlock |
| 4 | Fluoroscopy | Biomedical | 4.00 | Growth | Interventional imaging capability |
| 5 | Digital X-Ray | Biomedical | 4.00 | Upgrade | Radiology modernization |
| 6 | Casualty Renovation | Project | 3.80 | Infra | ER capacity enhancement & patient flow |
| 7 | Digital Microscope | Biomedical | 3.00 | Growth | Pathology digitization — onco enabler |
| 8 | Fire Curtains | Fire & Safety | 2.73 | Mandatory | Statutory safety requirement |
| 9 | Network Core Switches | IT | 2.50 | Digital | Oracle Health backbone infra |
| 10 | Heart Lung Machine | Biomedical | 2.50 | Growth | Cardiac surgery capability build |
| 11 | Ventilators (Paed + Adult) | Biomedical | 2.50 | Upgrade | ICU capacity expansion |
| 12 | Digital Slide Scanner | Biomedical | 2.50 | Growth | Onco pathology digitization |
| 13 | Tomotherapy Equipment | Biomedical | 2.30 | Growth | Cancer treatment anchor — Burjeel playbook |
| 14 | ICU Complex | Project | 2.25 | Infra | ICU consolidation — staff efficiency |
| 15 | Intraop Ultrasound | Biomedical | 2.20 | Upgrade | Surgical precision upgrade |
| 16 | Ultrasound Machine | Biomedical | 2.00 | Upgrade | Radiology refresh |
| 17 | Regularization (Fee) | Project | 1.64 | Mandatory | Legal / statutory compliance |
| 18 | Ultrasound & Ortho Reno | Project | 1.60 | Infra | OPD space optimization |
| 19 | Renal Transplant Centre | Project | 1.50 | Growth | Transplant vertical expansion |
| 20 | Paediatric OP Construction | Project | 1.50 | Infra | Patient-friendly OPD expansion |
Cancer & Oncology Capex — Strategic Sub-Analysis
🎯 Strategic Review: Cancer Relevance of Biomedical Capex
Of ₹95.3 Cr biomedical capex, ₹24.3 Cr (25.5%) is DIRECTLY or HIGHLY relevant to cancer/transplant programs — including tomotherapy (₹2.3 Cr), brachytherapy sources (₹0.4 Cr), digital pathology (₹5.5 Cr), and oncology ICU equipment. A further ₹25.7 Cr (26.9%) is MODERATELY relevant (shared imaging, ICU ventilators, monitors). The remaining ₹45.4 Cr (47.6%) serves general hospital operations — spine robotics (₹12 Cr), biplane cathlab (₹11 Cr), and routine replacements. See separate Excel for full item-level assessment.
Cancer Relevance of Biomedical Capex (₹95.3 Cr)
DIRECT = onco-specific · HIGH = transplant/pathology · MODERATE = shared clinical · LOW = general
Utility Classification — All 261 Biomedical Items
New capability vs end-of-life replacement vs other
DIRECT & HIGH Cancer-Aligned Items — ₹24.3 Cr (41 items)
Core investments supporting cancer transformation thesis
| # | Equipment | Location | Cost ₹L | Cancer Tag | Justification |
|---|
| 1 | Digital Microscope | Histopathology | 300.0 | Direct Onco Dx | New capability — cancer pathology digitization |
| 2 | Digital Slide Scanner | Histopathology | 250.0 | Direct Onco Dx | New — enables remote onco-pathology review |
| 3 | Tomotherapy Equipment | Radiotherapy | 230.0 | Direct Onco | Cancer treatment anchor — Burjeel playbook |
| 4 | PET Scan Upgradation | Nuclear Medicine | 100.0 | Direct Onco | Upgrade — cancer staging & monitoring |
| 5 | Multipara Monitor (×4) | ONCICU | 20.0 | Onco Location | New — oncology ICU build-out |
| 6 | Brachytherapy HDR Source Ir-192 (×4) | Radiotherapy | 40.0 | Direct Onco | New — HDR brachytherapy capability |
| 7 | Dose Calibrator (×2) | Nuclear Medicine | 20.0 | Direct Onco | Replacement — nuclear medicine dosing |
| 8 | Anesthesia Machine | Radiotherapy | 25.0 | Onco Location | Replacement — radiotherapy sedation |
| 9 | Ultrasound Machine | Radiotherapy | 25.0 | Onco Location | New — radiotherapy imaging guidance |
| 10 | Breast Board (Patient Positioning) | Radiotherapy | 0.6 | Direct Onco | New — breast cancer RT positioning |
| 11 | Microwave Ablation System | Interventional Radiology | 28.0 | Onco-Surgical | New — tumor ablation capability |
| 12 | RF Ablation System | Radiology | 25.0 | Onco-Surgical | Replacement — tumor ablation |
| 13 | Surgical Aspirator - CUSA | Neuro OT | 60.0 | Onco-Surgical | Replacement — used in brain tumor surgery |
| 14 | Penumbra Aspiration Pump | Interventional Radiology | 4.0 | Interventional | New — thrombectomy/onco-interventional |
| 15 | Ventilator | BMT | 25.0 | BMT/Transplant | New — bone marrow transplant unit |
| 16 | Infusion Pump | BMT | 0.5 | BMT/Transplant | New — BMT infusion support |
| — | + 25 more items (syringe pumps, monitors, immunofluorescence microscope, cytocentrifuge, molecular biology freezers, etc.) | |
| TOTAL DIRECT + HIGH | | ₹24.3 Cr | 41 items | |
Cancer Capex Summary
₹ Crore by relevance tier
DIRECT (Onco-specific)
₹10.6 Cr
HIGH (BMT/Path/IR)
₹13.6 Cr
MODERATE (Shared)
₹25.7 Cr
LOW/NONE (General)
₹45.4 Cr
By Utility/Justification
New vs replacement split
End-of-Life Replace
₹22.8 Cr
Key Takeaway
Strategic assessment
→ 25.5% of biomed capex is cancer-aligned
→ 62% is new capability (not just replacement)
→ Top 3 cancer items: digital pathology ₹5.5 Cr, tomotherapy ₹2.3 Cr, PET upgrade ₹1 Cr
→ ₹45 Cr in general items driven by spine robotics + cathlab
Staff / Bed
3.8x
Benchmark: 3.0-3.5x tertiary
Rev / Employee
₹25.3L
₹550 Cr / 2,173 on-roll
People Cost / Bed / Mo
₹2.95L
₹202 Cr / 570 beds / 12
Benefits Load
12.5%
₹6.5 Cr on ₹52 Cr base
Clinical : Non-Clin
58:42
1,260 vs 913 staff
Fixed : Variable
65:35
₹131 Cr fixed cost
Avg Annual Cost per Person by Category (₹ Lakhs)
Consultants cost 10x more than outsource staff per head
Clinical vs Non-Clinical / Fixed vs Variable
Two strategic lenses on cost structure
Benefits & Statutory Cost Stack
Non-salary cost components · ₹6.5 Cr total
| Component | Annual ₹ Cr | % of Base | Note |
|---|
| PF Employer Contribution | 3.13 | 6.0% | 12% of basic up to ₹15K |
| Gratuity | 1.20 | 2.3% | Actuarial provision |
| Exgratia | 0.81 | 1.6% | Annual gratitude payment |
| Holiday Compensation | 0.67 | 1.3% | Shift-based roles |
| PF Admin & EDLI | 0.26 | 0.5% | Statutory charge |
| PL Encashment | 0.21 | 0.4% | Accrued leave monetization |
| ESI Employer | 0.08 | 0.2% | Employees below ₹21K threshold |
| Bonus | 0.09 | 0.2% | Statutory bonus |
| Total Benefits Load | 6.45 | 12.5% | |
Kochi vs Calicut vs FNB
Multi-unit cost split
Increment Impact
8% staff + 10% doctor
HR Overhead Costs
Non-salary people expenses
Monthly People Cost Phasing — FY27 (₹ Lakhs)
Grand total across Kochi + Calicut + FNB + Outsource
Monthly Phasing Detail
Kochi unit staff & doctor breakdown (Calicut & FNB in Grand Total) · Grand Total = all 3 units + outsource
| Month | Staff Salary ₹L | Doctor Fees ₹L | Outsource ₹L | Grand Total ₹L |
|---|
| Apr 26 | 716.5 | 788.0 | 107.5 | 1,653.8 |
| May 26 | 718.9 | 800.3 | 107.5 | 1,668.6 |
| Jun 26 | 713.9 | 807.0 | 107.5 | 1,670.4 |
| Jul 26 | 719.0 | 824.7 | 107.5 | 1,693.6 |
| Aug 26 | 723.9 | 804.3 | 107.5 | 1,677.6 |
| Sep 26 | 713.9 | 822.1 | 107.5 | 1,685.7 |
| Oct 26 | 715.0 | 815.2 | 107.5 | 1,679.7 |
| Nov 26 | 713.9 | 821.3 | 107.5 | 1,684.7 |
| Dec 26 | 718.9 | 828.5 | 107.5 | 1,697.1 |
| Jan 27 | 714.0 | 827.4 | 107.5 | 1,691.0 |
| Feb 27 | 713.9 | 820.0 | 107.5 | 1,683.3 |
| Mar 27 | 713.9 | 834.9 | 107.5 | 1,698.4 |
| FY27 | 8,596 | 9,794 | 1,290 | 20,184 |
🎯 Five Strategic Cost Levers Identified
Total addressable savings: ₹15-25 Cr annually (5-8% of cost base) without compromising clinical quality or transformation objectives. Levers range from quick wins (vendor consolidation, 3-6 months) to structural shifts (productivity improvement, 12-18 months).
1Productivity Improvement — Staff-to-Bed OptimizationHIGH IMPACT₹8-12 Cr · 12-18 months
| Metric | Current | Target | Gap |
|---|
| Staff / Bed | 3.8x | 3.3x | -285 FTE |
| Nursing / Bed | 1.2x | 1.1x | -57 FTE |
| Admin / Bed | 0.95x | 0.75x | -114 FTE |
→ Oracle Health digitization to reduce manual workflows
→ Cross-train admin staff across PCS, billing, MRD
→ ICU consolidation (already planned) for nursing efficiency
→ Attrition-based headcount reduction (natural churn)
2Doctor Economics — Revenue-Linked Fee RestructuringHIGH IMPACT₹3-5 Cr · 6-12 months
| Component | FY27 ₹ Cr | % of Rev |
|---|
| Fixed Professional Fee | 60.7 | 11.0% |
| Revenue Incentive (2.68%) | 13.2 | 2.4% |
| Visiting Consultant Share | 8.3 | 1.5% |
| Total | 82.2 | 14.9% |
→ Shift new hires to higher variable / lower fixed structure
→ Tie incentives to EBITDA contribution, not just top-line
→ Review bottom-quartile consultant contracts
→ Leverage VPS brand to attract talent competitively
3Outsource Vendor ConsolidationQUICK WIN₹1-2 Cr · 3-6 months
→ 3 HK vendors with ₹11K/month cost spread — consolidate to 1-2 vendors
→ Negotiate volume-based pricing (194 HK staff = significant bargaining power)
→ Evaluate insourcing for stable long-term roles (ward boys, nursing assistants)
→ Single-vendor risk for 175 security/ward boy staff (Utiz) — add backup vendor
4Capex Prioritization — Phase & Defer Non-CriticalSTRATEGIC₹5-8 Cr deferral
| Priority | ₹ Cr | Items |
|---|
| Must-Have Transformation | 76 | 43 |
| Should-Have Upgrades | 23 | 223 |
| Could-Defer Beautification | 8 | ~40 |
| Mandatory Safety | 3.4 | 4 |
→ Beautification items (painting, walkway, porch): ₹2.2 Cr deferrable
→ Premium suite & room renovations: ₹0.6 Cr
→ Vehicle purchases (Innova Hycross): ₹0.7 Cr
→ Phase 237 equipment items by utilization urgency
5Revenue Mix Shift — Operating Leverage via ARPOB GrowthTRANSFORMATION₹5-10 Cr EBITDA · 12-24 months
→ ARPOB growth from ₹49K → ₹70K drives revenue without proportional cost increase
→ Cancer & complex care = 50-85% ARPOB premium vs multi-specialty
→ Fixed cost base (~₹131 Cr) creates natural operating leverage
→ Every ₹1K ARPOB increase at 570 beds = ~₹21 Cr incremental revenue
Total Savings Target
₹18-28 Cr
5.4-8.4% of ₹332 Cr cost base
Phase 1 Quick Wins
₹4-7 Cr
Days 1-30 · Immediate actions
Phase 2 Structural
₹6-10 Cr
Days 31-60 · Process reforms
Phase 3 Transform
₹8-11 Cr
Days 61-100 · Revenue leverage
Target People/Rev
34.0%
From 36.7% · 270 bps improvement
Target Staff/Bed
3.3x
From 3.8x · Benchmark aligned
🚨 100-Day Mission: From Cost Management to Bare Efficiency
This plan targets ₹18-28 Cr in annualized savings across three phases — quick wins (vendor consolidation, capex deferrals), structural reforms (doctor economics, staffing productivity), and transformation (ARPOB growth, operating leverage). The hospital is debt-free with ₹332 Cr cost base and 19.4% EBITDA margin. The goal is to reach 22-24% EBITDA while maintaining clinical transformation investments. Each phase has clear owners, weekly milestones, and measurable KPIs.
100-Day Execution Timeline
3 phases · 14 workstreams · Weekly checkpoint rhythm
Phase 1 — Days 1-30: Quick Wins & Diagnostics (₹4-7 Cr Savings)
1Outsource Vendor Consolidation & RenegotiationQUICK WIN₹1.5-2.0 Cr · Week 1-4
| Action | Week | Expected Impact |
|---|
| Audit all 5 vendor contracts & benchmark rates | Week 1 | Baseline established |
| Issue consolidated RFP for housekeeping (194 staff across 3 vendors) | Week 2 | ₹11K/head spread identified |
| Negotiate volume discount — target ₹20K/head blended (from ₹22.5K avg) | Week 3 | ₹58L annual savings |
| Consolidate to 2 vendors max, introduce penalty clauses for SLA breach | Week 4 | ₹1.0-1.5 Cr savings locked |
| Add backup vendor for Utiz-dependent security/ward boy (175 staff) | Week 4 | Risk mitigation + price pressure |
Current State
3 HK vendors: Naipunnya (₹22.4K), Prof. Hospitality (₹28.7K), Abad (₹17.1K). Spread = ₹11K/head/month. Total outsource: ₹12.9 Cr for 416 staff.
2Immediate Capex Deferrals — Non-Clinical ItemsQUICK WIN₹2.0-3.5 Cr · Week 1-2
| Deferrable Item | ₹ Cr | Rationale |
|---|
| Building painting & walkway beautification | 2.20 | Cosmetic — no clinical impact |
| Vehicle purchase (Innova Hycross) | 0.70 | Lease or defer 6 months |
| Premium suite renovations | 0.60 | Revenue impact < 0.2% of total |
| Porch & entrance redesign | 0.45 | Aesthetic improvement only |
| Total Deferrable | 3.95 | |
Protect all clinical capex (₹99 Cr) — spine robotics, biplane cathlab, tomotherapy, and oncology equipment remain untouched. These are the transformation thesis.
→ Freeze all non-clinical capex orders not yet committed
→ Renegotiate payment terms on committed infrastructure items (extend from 30 to 90 days)
→ Create capex release committee — weekly approvals required for items > ₹10L
3Energy, Consumables & Procurement AuditQUICK WIN₹0.5-1.5 Cr · Week 2-4
→ Engage energy auditor for HVAC, lighting, and power optimization across 3 units
→ Benchmark medical consumables pricing against GPO (group purchasing organization) rates
→ Review pharmacy procurement margins — current pharmacy revenue ₹34 Cr, potential 2-3% margin improvement via formulary standardization
→ Audit dietary/F&B costs — 88 staff at ₹298L cost, benchmark against outsource (could save ₹50-80L)
→ Implement just-in-time inventory for high-cost surgical consumables
Phase 2 — Days 31-60: Structural Reforms (₹6-10 Cr Savings)
4Doctor Fee Restructuring — New Hire Model OverhaulHIGH IMPACT₹2-4 Cr · Week 5-8
| Component | Current Model | Target Model |
|---|
| Fixed:Variable ratio | 78:22 | 55:45 |
| New hire fixed fee | ₹3.2L/mo avg | ₹2.0L/mo + incentive |
| Incentive trigger | Revenue-based (2.68%) | EBITDA-linked + volume |
| Bottom-quartile review | No formal review | Annual performance gate |
Doctor cost = ₹99 Cr (49% of people cost). The structural problem: 61% is fixed professional fee (₹61 Cr) with no revenue linkage.
→ All 41 new FY27 hires on revised structure — saves ₹2-3 Cr vs old model
→ Bottom-quartile consultant review (docs generating < ₹50L revenue against ₹3.2L/mo fee)
→ Visiting consultant share (₹8.3 Cr): cap at 8% for Calicut (from 10%)
→ New incentive: EBITDA contribution bonus replaces revenue-only incentive
5Staffing Productivity — Attrition-Based Right-SizingHIGH IMPACT₹3-4 Cr · Week 5-8
| Category | Current | Target | Reduction |
|---|
| Staff/Bed overall | 3.8x | 3.3x | ~285 FTE |
| Admin staff | 539 | 430 | 109 via attrition |
| Non-clinical FTE | 913 (42%) | 780 (36%) | 133 over 12mo |
| Nursing/Bed | 1.2x | 1.1x | 57 via ICU consolidation |
→ Hiring freeze on non-clinical roles — natural attrition (~12-15% annually) will reduce 80-100 FTEs in 6 months
→ Cross-train PCS, billing, MRD staff to create multi-skilled admin pool
→ ICU consolidation (already in capex plan — ₹2.25 Cr) enables 15-20% nursing efficiency
→ Shift-optimization study for nursing — eliminate overlap between 7am-3pm and 2pm-10pm shifts
→ Oracle Health digitization roadmap to automate manual workflows (billing, MRD, scheduling)
6Increment Rationalization & Benefits OptimizationMODERATE₹1-2 Cr · Week 6-8
Current increment budget: ₹10 Cr (Staff 8% + Doctor 10%). Benefits load: ₹6.45 Cr (12.5% of base).
→ Performance-linked increments: top 30% get 10-12%, middle 50% get 6%, bottom 20% get 0-3%
→ Cap doctor increment at 7% (from 10%) — saves ₹1.6 Cr on ₹61 Cr base
→ Review exgratia (₹81L) — convert to performance-linked discretionary bonus
→ PL encashment (₹21L) — encourage leave utilization vs. encashment
→ Holiday compensation (₹67L) — optimize shift scheduling to reduce comp-off accumulation
Current Increment
₹10.0 Cr
Phase 3 — Days 61-100: Transformation & Revenue Leverage (₹8-11 Cr EBITDA Impact)
7ARPOB Growth — Operating Leverage via Case Mix ShiftTRANSFORMATION₹5-8 Cr EBITDA · Week 9-14
| Metric | Day 1 | Day 100 | FY29 Target |
|---|
| ARPOB | ₹49K | ₹53K | ₹70K |
| Occupancy | 62% | 65% | 72% |
| Complex care % | ~18% | 22% | 35% |
| Insurance mix | 26% | 28% | 35% |
Every ₹1K increase in ARPOB at 570 beds = ₹21 Cr incremental revenue. At 65% fixed costs, that's ₹7 Cr straight to EBITDA.
→ Fast-track oncology OPD clinic launches — medical oncology, head & neck (6 new docs hired)
→ Spine robotics go-live preparation (₹12 Cr investment) — first-mover in Kerala
→ Insurance panel expansion — target 3 new TPA empanelments per month
→ Package pricing redesign for complex procedures (15-20% ARPOB premium)
8OPD-to-IPD Conversion & Revenue Leakage PlugREVENUE₹2-3 Cr · Week 9-14
OP revenue = ₹92 Cr (25.7% of total). IP revenue = ₹267 Cr (74.3%). A 1% improvement in OPD-to-IPD conversion = ₹3-4 Cr additional IP revenue.
→ Audit OPD-to-IPD conversion rates by department — identify bottom performers
→ Implement CRM-style patient follow-up for OP consultations recommending surgery/procedures
→ Revenue leakage audit: unbilled services, missed charges, underpriced procedures
→ Cross-referral incentive program between departments (e.g., ortho → physio → rehab)
→ Reduce concentration risk: top 2 doctors = 20.7% of revenue — activate next 10 doctors with volume targets
9Digital & Process Automation — Oracle Health FoundationENABLER₹1-2 Cr (Year 2) · Week 10-14
IT capex budget: ₹5 Cr (network core switches ₹2.5 Cr as Oracle Health backbone). Process automation is the long-term efficiency lever.
→ Finalize Oracle Health implementation roadmap — target billing & scheduling modules first
→ Digitize MRD workflows (3 outsourced MRD assistants + 50+ manual processes)
→ Automate appointment scheduling, bed management, and discharge planning
→ Patient self-service kiosks for registration (reduce PCS staff workload by 20-30%)
→ Analytics dashboard for real-time bed occupancy, OT utilization, and revenue per doctor
Savings Impact Summary
100-Day Savings Waterfall (₹ Crore — Annualized)
Conservative to optimistic range · Total: ₹18-28 Cr
EBITDA Margin Impact Trajectory
From 19.4% current to 22-24% target
Governance & Accountability Framework
100-Day Execution Governance
Weekly cadence · Named owners · Board-level oversight
| Workstream | Owner | Weekly KPI | Day 30 Gate | Day 60 Gate | Day 100 Gate |
|---|
| Vendor Consolidation | Head - Admin/Procurement | Vendor meetings, RFP status | Contracts signed | Savings realized | ₹1.5 Cr locked |
| Capex Freeze | CFO + Engineering Head | PO approvals, deferrals | ₹3.5 Cr frozen | Committee active | Tracking rhythm |
| Doctor Economics | CEO + Medical Director | Contract reviews completed | Model designed | New hires on new model | Bottom-Q reviewed |
| Staffing Productivity | CHRO + COO | Attrition fill rate, FTE count | Freeze in place | 50 FTE absorbed | 100 FTE absorbed |
| Increment Reform | CHRO + CFO | Policy draft, approval | Policy drafted | Board approved | Implemented |
| ARPOB Growth | CEO + Dept Heads | Complex case count, ARPP | Baseline set | Clinics launched | ₹53K ARPOB |
| Revenue Leakage | Revenue Cycle Lead | Unbilled %, conversion rate | Audit complete | Fixes deployed | 1% conversion lift |
| Digital/Oracle Health | CIO + IT Head | Module go-live milestones | RFP finalized | Phase 1 kick-off | Billing live |
Weekly Cadence
Non-negotiable rhythm
Monday 8 AM: CEO war room — 8 workstream leads, 15 min each
Wednesday 4 PM: CFO savings tracker — actuals vs targets
Friday 5 PM: Board update — 1-page scorecard emailed
Day 30: Phase 1 gate review — CEO + Board
Day 60: Phase 2 gate review — full Board meeting
Day 100: Transformation report — P&L impact validated
Risk Register
Top 5 execution risks
HIGH Doctor pushback on fee restructure
HIGH Key person dependency (top 2 = 20.7% rev)
MED Staff morale during hiring freeze
MED Vendor transition quality disruption
LOW Oracle Health implementation delays
Success Metrics — Day 100
Board-reportable KPIs
Annualized Savings
₹18+ Cr